Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
Authors
Keywords
-
Journal
BIODRUGS
Volume 36, Issue 2, Pages 95-103
Publisher
Springer Science and Business Media LLC
Online
2022-03-22
DOI
10.1007/s40259-022-00517-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review
- (2021) Robert T. Keenan et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
- (2021) Puja P. Khanna et al. Arthritis & Rheumatology
- POS1122 PRELIMINARY FINDINGS OF THE PROTECT CLINICAL TRIAL: PEGLOTICASE EFFICACY AND SAFETY IN KIDNEY TRANSPLANT RECIPIENTS
- (2021) A. Abdellatif et al. ANNALS OF THE RHEUMATIC DISEASES
- ImmTORTM to amplify the efficacy and reduce immunogenicity of biologics
- (2021) Carsten Brunn et al. Emerging Topics in Life Sciences
- Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity
- (2020) Riccardo Moia et al. HEMATOLOGICAL ONCOLOGY
- Methotrexate and its mechanisms of action in inflammatory arthritis
- (2020) Bruce N. Cronstein et al. Nature Reviews Rheumatology
- 2020 American College of Rheumatology Guideline for the Management of Gout
- (2020) John D. FitzGerald et al. ARTHRITIS CARE & RESEARCH
- Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
- (2020) Takashi Kei Kishimoto Frontiers in Immunology
- Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
- (2020) Yen-Ju Lin et al. Cells
- Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
- (2020) John A. Albert et al. Rheumatology and Therapy
- Pretreatment and Coadministration With Methotrexate Improved Durability of Pegloticase Response
- (2020) John K. Botson et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Pegloticase in combination with methotrexate in patients with uncontrolled gout: A multicenter, open-label study (MIRROR)
- (2020) John K. Botson et al. JOURNAL OF RHEUMATOLOGY
- Systemic Urate Deposition: An Unrecognized Complication of Gout?
- (2020) Puja Khanna et al. Journal of Clinical Medicine
- Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al
- (2019) Hubert Marotte et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
- (2019) Vibeke Strand et al. BIODRUGS
- A Case Report of Immunosuppressant Medication-associated Polyarticular Tophaceous Gout Successfully Treated Using the Polyethylene Glycol-conjugated Uricase Enzyme Pegloticase
- (2018) Brigid Freyne TRANSPLANTATION PROCEEDINGS
- Recapture and improved outcome of pegloticase response with methotrexate–A report of two cases and review of the literature
- (2018) Sarah Y. Bessen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with gout
- (2017) Adey A. Berhanu et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
- (2016) Takashi K. Kishimoto et al. Nature Nanotechnology
- The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
- (2015) Elisabeth Lie et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
- (2015) Katherine C. Allen et al. DRUG SAFETY
- Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
- (2015) Herbert S. B. Baraf et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- O-003 Relationship Between Vedolizumab Pharmacokinetics and Endoscopic Outcomes of Patients With Ulcerative Colitis
- (2014) Rosario Maria et al. INFLAMMATORY BOWEL DISEASES
- Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
- (2014) Roberto A. Maldonado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolutionary history and metabolic insights of ancient mammalian uricases
- (2014) J. T. Kratzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
- (2014) Peter E Lipsky et al. ARTHRITIS RESEARCH & THERAPY
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
- (2012) Yanyan Zhu et al. AMERICAN JOURNAL OF MEDICINE
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
- (2012) Charlotte L Krieckaert et al. ANNALS OF THE RHEUMATIC DISEASES
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Therapeutic perspectives on uricases for gout
- (2012) Ricardo P. Garay et al. JOINT BONE SPINE
- Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
- (2011) Robert T. Keenan et al. AMERICAN JOURNAL OF MEDICINE
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The aging of the immune system
- (2009) Daniela Weiskopf et al. TRANSPLANT INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now